Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2693]

European Commission approves enfortumab vedotin in combination with pembrolizumab as the first and only approved perioperative treatment option for cisplatin-ineligible patients with resectable muscle-invasive bladder cancer

European Commission approves enfortumab vedotin in combination with pembrolizumab as the first and only approved...

Study finds prostate cancer screening discussions are rare – but make a big difference

Study finds prostate cancer screening discussions are rare – but make a big difference

Lifestyle factors may influence prostate cancer risk in Indian men

Lifestyle factors may influence prostate cancer risk in Indian men

Common aging mechanisms may link vision loss disorder to increased risk of certain cancers

Common aging mechanisms may link vision loss disorder to increased risk of certain cancers

Many cancers evolve through early bursts of chromosome changes and originate from a single cancer cell

Many cancers evolve through early bursts of chromosome changes and originate from a single cancer cell

A new route to kill resistant bladder cancer cells

A new route to kill resistant bladder cancer cells

Machine learning model improves accuracy of liquid biopsy results

Machine learning model improves accuracy of liquid biopsy results

B7x drives resistance to PD-1/PD-L1 blockade in bladder cancer

B7x drives resistance to PD-1/PD-L1 blockade in bladder cancer

New theranostic approach effectively detects and treats neuroendocrine prostate cancer

New theranostic approach effectively detects and treats neuroendocrine prostate cancer

Can taking aspirin uncover asymptomatic bladder cancer?

Can taking aspirin uncover asymptomatic bladder cancer?

More from ecancer